Literature DB >> 30671806

Absorbable Polyglactin vs. Non-Cross-linked Porcine Biological Mesh for the Surgical Treatment of Infected Incisional Hernia.

Yohann Renard1, Louis de Mestier2, Julie Henriques3, Paul de Boissieu4, Philippe de Mestier5, Abe Fingerhut6, Jean-Pierre Palot7, Reza Kianmanesh7.   

Abstract

BACKGROUND: The use of absorbable meshes during contaminated or infected incisional hernia (IH) repair is associated with high morbidity and recurrence rates. Biological meshes might be more appropriate but have been described in highly heterogeneous series. This study aimed at comparing the efficacy of absorbable vs. biological meshes for the treatment of contaminated or infected IH in a homogeneous series with a standardized technique.
METHODS: Data of all patients operated on between 2008 and 2015 for contaminated or infected IH, using an absorbable (A) Vicryl® or a biological (B) Strattice® mesh, were reviewed. Patient characteristics, infectious complication rates, and recurrence-free outcome (RFO) were compared between the two groups. A propensity score methodology was applied to a Cox regression model to deal with unbalanced characteristics between groups.
RESULTS: Patient demographics in A (n = 57) and in B (n = 24) were similar except that B patients had larger parietal defects (p < 0.001) and higher Center for Disease Control (CDC) wound class (p = 0.034). Patients in A had statistically significantly more postoperative early (61.4% vs. 33.3%, p = 0.03) and late (31.2% vs. 8.3%, p = 0.046) infectious complications. Six-, 12-, and 36-month RFO rates were 77%, 47%, and 24%, and 96%, 87%, and 82% in A and B, respectively, p < 0.001. Raw multivariable Cox regression analysis found that B (HR = 0.1, 95% CI [0.03-0.34], p < 0.001) was independently associated with prolonged RFO (HR = 0.091, 95% CI [0.045-0.180], p < 0.001).
CONCLUSION: Biological meshes seem to be superior to absorbable meshes in patients with contaminated or infected incisional hernia. These results need to be confirmed by prospective randomized trials.

Entities:  

Keywords:  Acellular dermis; Collagen/therapeutic use; Extracellular matrix; Hernia; Herniorrhaphy/methods; Surgical mesh; Surgical wound infection/epidemiology; Surgical wound infection/prevention and control; Ventral/surgery; Wound healing

Mesh:

Substances:

Year:  2019        PMID: 30671806     DOI: 10.1007/s11605-018-04095-8

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  45 in total

1.  Long-term outcomes (>5-year follow-up) with porcine acellular dermal matrix (Permacol) in incisional hernias at risk for infection.

Authors:  M M Abdelfatah; N Rostambeigi; E Podgaetz; M G Sarr
Journal:  Hernia       Date:  2013-10-16       Impact factor: 4.739

2.  [Economic evaluation of medical devices not included in the French list of products and services qualifying for reimbursement: Example of biologic meshes].

Authors:  A Sainfort; I Denis-Hallouard; G Aulagner; O Nuiry; X Armoiry
Journal:  Ann Pharm Fr       Date:  2017-03-16

3.  Use of mesh during ventral hernia repair in clean-contaminated and contaminated cases: outcomes of 33,832 cases.

Authors:  Jacqueline J Choi; Nandini C Palaniappa; Kai B Dallas; Tamara B Rudich; Modesto J Colon; Celia M Divino
Journal:  Ann Surg       Date:  2012-01       Impact factor: 12.969

4.  Activation of human mononuclear cells by porcine biologic meshes in vitro.

Authors:  S B Orenstein; Y Qiao; U Klueh; D L Kreutzer; Y W Novitsky
Journal:  Hernia       Date:  2010-02-10       Impact factor: 4.739

Review 5.  A decade of ventral incisional hernia repairs with biologic acellular dermal matrix: what have we learned?

Authors:  Nicole A Kissane; Kamal M F Itani
Journal:  Plast Reconstr Surg       Date:  2012-11       Impact factor: 4.730

6.  A 5-year clinical experience with single-staged repairs of infected and contaminated abdominal wall defects utilizing biologic mesh.

Authors:  Michael J Rosen; David M Krpata; Bridget Ermlich; Jeffrey A Blatnik
Journal:  Ann Surg       Date:  2013-06       Impact factor: 12.969

7.  The use of a subfascial vicryl mesh buttress to aid in the closure of massive ventral hernias following damage-control laparotomy.

Authors:  Adam M Tobias; David W Low
Journal:  Plast Reconstr Surg       Date:  2003-09       Impact factor: 4.730

Review 8.  Suture Versus Mesh Repair in Primary and Incisional Ventral Hernias: A Systematic Review and Meta-Analysis.

Authors:  Tim Mathes; Maren Walgenbach; Robert Siegel
Journal:  World J Surg       Date:  2016-04       Impact factor: 3.352

Review 9.  A systematic review of outcomes following repair of complex ventral incisional hernias with biologic mesh.

Authors:  Stephen J Ferzoco
Journal:  Int Surg       Date:  2013 Oct-Dec

10.  Multicenter, Prospective, Longitudinal Study of the Recurrence, Surgical Site Infection, and Quality of Life After Contaminated Ventral Hernia Repair Using Biosynthetic Absorbable Mesh: The COBRA Study.

Authors:  Michael J Rosen; Joel J Bauer; Marco Harmaty; Alfredo M Carbonell; William S Cobb; Brent Matthews; Matthew I Goldblatt; Don J Selzer; Benjamin K Poulose; Bibi M E Hansson; Camiel Rosman; James J Chao; Garth R Jacobsen
Journal:  Ann Surg       Date:  2017-01       Impact factor: 12.969

View more
  7 in total

1.  Safety and efficacy of prophylactic resorbable biosynthetic mesh following midline laparotomy in clean/contemned field: preliminary results of a randomized double blind prospective trial.

Authors:  F Pizza; D D'Antonio; M Arcopinto; C Dell'Isola; A Marvaso
Journal:  Hernia       Date:  2019-08-20       Impact factor: 4.739

Review 2.  Ventral hernia repair in high-risk patients and contaminated fields using a single mesh: proportional meta-analysis.

Authors:  S Morales-Conde; P Hernández-Granados; L Tallón-Aguilar; M Verdaguer-Tremolosa; M López-Cano
Journal:  Hernia       Date:  2022-09-13       Impact factor: 2.920

3.  The Association of Coloproctology of Great Britain and Ireland consensus guidelines in emergency colorectal surgery.

Authors:  Andrew S Miller; Kathryn Boyce; Benjamin Box; Matthew D Clarke; Sarah E Duff; Niamh M Foley; Richard J Guy; Lisa H Massey; George Ramsay; Dominic A J Slade; James A Stephenson; Phil J Tozer; Danette Wright
Journal:  Colorectal Dis       Date:  2021-02       Impact factor: 3.917

4.  A systematic review of outcome reporting in incisional hernia surgery.

Authors:  D Harji; C Thomas; S A Antoniou; H Chandraratan; B Griffiths; B T Henniford; L Horgan; F Köckerling; M López-Cano; L Massey; M Miserez; A Montgomery; F Muysoms; B K Poulose; W Reinpold; N Smart
Journal:  BJS Open       Date:  2021-03-05

Review 5.  Clinical applications of acellular dermal matrices: A review.

Authors:  Kyla Petrie; Cameron T Cox; Benjamin C Becker; Brendan J MacKay
Journal:  Scars Burn Heal       Date:  2022-01-19

Review 6.  An Evaluation of the Evidence Guiding Adult Midline Ventral Hernia Repair.

Authors:  Alex Sagar; Niteen Tapuria
Journal:  Surg J (N Y)       Date:  2022-08-02

7.  Slowly absorbable mesh versus standard care in the management of contaminated midline incisional hernia (COMpACT-BIO): a multicentre randomised controlled phase III trial including a health economic evaluation.

Authors:  Guillaume Passot; Jennifer Margier; Amaniel Kefleyesus; Pascal Rousset; Pablo Ortega-Deballon; Yohann Renard; Sylvie Bin; Laurent Villeneuve
Journal:  BMJ Open       Date:  2022-08-25       Impact factor: 3.006

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.